India · Delayed Price · Currency is INR Dr. Reddy's Laboratories Statistics
Total Valuation
NSE:DRREDDY has a market cap or net worth of INR 1.09 trillion. The enterprise value is 1.08 trillion.
| Market Cap | 1.09T |
| Enterprise Value | 1.08T |
Important Dates
The last earnings date was Friday, October 23, 2026.
| Earnings Date | Oct 23, 2026 |
| Ex-Dividend Date | Jul 10, 2026 |
Share Statistics
| Current Share Class | 833.07M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.05% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | 26.72% |
| Owned by Institutions (%) | 58.94% |
| Float | 600.06M |
Valuation Ratios
The trailing PE ratio is 39.04 and the forward PE ratio is 24.98.
| PE Ratio | 39.04 |
| Forward PE | 24.98 |
| PS Ratio | 3.29 |
| PB Ratio | 2.79 |
| P/TBV Ratio | 4.03 |
| P/FCF Ratio | 78.42 |
| P/OCF Ratio | 35.12 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.07, with an EV/FCF ratio of 78.37.
| EV / Earnings | 38.76 |
| EV / Sales | 3.29 |
| EV / EBITDA | 21.07 |
| EV / EBIT | 36.08 |
| EV / FCF | 78.37 |
Financial Position
The company has a current ratio of 1.93, with a Debt / Equity ratio of 0.19.
| Current Ratio | 1.93 |
| Quick Ratio | 1.15 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 1.40 |
| Debt / FCF | 5.22 |
| Interest Coverage | 6.67 |
Financial Efficiency
Return on equity (ROE) is 7.34% and return on invested capital (ROIC) is 6.17%.
| Return on Equity (ROE) | 7.34% |
| Return on Assets (ROA) | 3.37% |
| Return on Invested Capital (ROIC) | 6.17% |
| Return on Capital Employed (ROCE) | 7.16% |
| Weighted Average Cost of Capital (WACC) | 5.58% |
| Revenue Per Employee | 11.98M |
| Profits Per Employee | 1.02M |
| Employee Count | 27,527 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 2.12 |
Taxes
In the past 12 months, NSE:DRREDDY has paid 7.64 billion in taxes.
| Income Tax | 7.64B |
| Effective Tax Rate | 21.69% |
Stock Price Statistics
The stock price has increased by +2.13% in the last 52 weeks. The beta is 0.25, so NSE:DRREDDY's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | +2.13% |
| 50-Day Moving Average | 1,194.66 |
| 200-Day Moving Average | 1,243.59 |
| Relative Strength Index (RSI) | 70.40 |
| Average Volume (20 Days) | 2,584,593 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:DRREDDY had revenue of INR 329.84 billion and earned 27.99 billion in profits. Earnings per share was 33.58.
| Revenue | 329.84B |
| Gross Profit | 163.24B |
| Operating Income | 30.06B |
| Pretax Income | 35.22B |
| Net Income | 27.99B |
| EBITDA | 49.79B |
| EBIT | 30.06B |
| Earnings Per Share (EPS) | 33.58 |
Balance Sheet
The company has 76.24 billion in cash and 72.29 billion in debt, with a net cash position of 3.96 billion.
| Cash & Cash Equivalents | 76.24B |
| Total Debt | 72.29B |
| Net Cash | 3.96B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 389.37B |
| Book Value Per Share | 463.56 |
| Working Capital | 143.08B |
Cash Flow
In the last 12 months, operating cash flow was 30.91 billion and capital expenditures -17.07 billion, giving a free cash flow of 13.84 billion.
| Operating Cash Flow | 30.91B |
| Capital Expenditures | -17.07B |
| Depreciation & Amortization | 19.73B |
| Net Borrowing | 11.32B |
| Free Cash Flow | 13.84B |
| FCF Per Share | n/a |
Margins
Gross margin is 49.49%, with operating and profit margins of 9.11% and 8.48%.
| Gross Margin | 49.49% |
| Operating Margin | 9.11% |
| Pretax Margin | 10.68% |
| Profit Margin | 8.48% |
| EBITDA Margin | 15.10% |
| EBIT Margin | 9.11% |
| FCF Margin | 4.20% |
Dividends & Yields
This stock pays an annual dividend of 8.00, which amounts to a dividend yield of 0.61%.
| Dividend Per Share | 8.00 |
| Dividend Yield | 0.61% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 23.81% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.05% |
| Shareholder Yield | 0.66% |
| Earnings Yield | 2.56% |
| FCF Yield | 1.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:DRREDDY is 1,350.97, which is 3.06% higher than the current price. The consensus rating is "Buy".
| Price Target | 1,350.97 |
| Price Target Difference | 3.06% |
| Analyst Consensus | Buy |
| Analyst Count | 37 |
| Revenue Growth Forecast (3Y) | 8.79% |
| EPS Growth Forecast (3Y) | 7.56% |
Stock Splits
The last stock split was on October 28, 2024. It was a forward split with a ratio of 5.
| Last Split Date | Oct 28, 2024 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
NSE:DRREDDY has an Altman Z-Score of 5.29 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.29 |
| Piotroski F-Score | 5 |